Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CIPROFLOXACIN

CIPROFLOXACIN

Standard Dose
400MG/40ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CIPROFLOXACIN is listed in Drugs@FDA under application 078062 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN Form and strength INJECTABLE;INJECTION - 400MG/40ML (10MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2019-05-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview CIPROFLOXACIN is listed in Drugs@FDA under application 078062 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN Form and strength INJECTABLE;INJECTION - 400MG/40ML (10MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2019-05-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.